ArticleCancer diagnosis & prognosis

Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease.

Sei Morinaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.